Earnings Per Share, Basic of INFINITY PHARMACEUTICALS, INC. from 30 Sep 2011 to 30 Jun 2023
- Taxonomy & unit
- us-gaap: USD/shares
- Description
- The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
- Summary
-
INFINITY PHARMACEUTICALS, INC. quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 30 Sep 2011 to 30 Jun 2023.
- INFINITY PHARMACEUTICALS, INC. Earnings Per Share, Basic for the quarter ending 30 Jun 2023 was -0.11, a 15% increase year-over-year.
- INFINITY PHARMACEUTICALS, INC. Earnings Per Share, Basic for the twelve months ending 30 Jun 2023 was 0, a 12% increase year-over-year.
- INFINITY PHARMACEUTICALS, INC. annual Earnings Per Share, Basic for 2022 was -0.5, a 5.7% increase from 2021.
- INFINITY PHARMACEUTICALS, INC. annual Earnings Per Share, Basic for 2021 was -0.53, a 22% increase from 2020.
- Source SEC data
- View on sec.gov
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)
INFINITY PHARMACEUTICALS, INC. Quarterly Earnings Per Share, Basic (USD/shares)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2023 | 0 | -0.11 | +0.02 | +15% | 01 Apr 2023 | 30 Jun 2023 | 10-Q | 10 Aug 2023 | 2023 | Q2 |
| Q1 2023 | 0 | -0.12 | +0.02 | +14% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 09 May 2023 | 2023 | Q1 |
| Q4 2022 | -1 | -0.11 | +0.02 | +15% | 01 Oct 2022 | 31 Dec 2022 | 10-K | 28 Mar 2023 | 2022 | FY |
| Q3 2022 | -1 | -0.12 | 0 | 0% | 01 Jul 2022 | 30 Sep 2022 | 10-Q | 14 Nov 2022 | 2022 | Q3 |
| Q2 2022 | -1 | -0.13 | 0 | 0% | 01 Apr 2022 | 30 Jun 2022 | 10-Q | 10 Aug 2023 | 2023 | Q2 |
| Q1 2022 | -1 | -0.14 | +0.01 | +6.7% | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 09 May 2023 | 2023 | Q1 |
| Q4 2021 | -1 | -0.13 | 01 Oct 2021 | 31 Dec 2021 | 10-K | 28 Mar 2023 | 2022 | FY | ||
| Q3 2021 | -0.12 | +0.04 | +25% | 01 Jul 2021 | 30 Sep 2021 | 10-Q | 14 Nov 2022 | 2022 | Q3 | |
| Q2 2021 | -0.13 | +0.03 | +19% | 01 Apr 2021 | 30 Jun 2021 | 10-Q | 09 Aug 2022 | 2022 | Q2 | |
| Q1 2021 | -0.15 | 01 Jan 2021 | 31 Mar 2021 | 10-Q | 03 May 2022 | 2022 | Q1 | |||
| Q3 2020 | -0.16 | +0.04 | +20% | 01 Jul 2020 | 30 Sep 2020 | 10-Q | 02 Nov 2021 | 2021 | Q3 | |
| Q2 2020 | -0.16 | 01 Apr 2020 | 30 Jun 2020 | 10-Q | 27 Jul 2021 | 2021 | Q2 | |||
| Q3 2019 | -0.2 | -0.43 | -187% | 01 Jul 2019 | 30 Sep 2019 | 10-Q | 30 Oct 2019 | 2019 | Q3 | |
| Q3 2018 | 0.23 | +0.37 | 01 Jul 2018 | 30 Sep 2018 | 10-Q | 30 Oct 2019 | 2019 | Q3 | ||
| Q3 2017 | -0.14 | +0.25 | +64% | 01 Jul 2017 | 30 Sep 2017 | 10-Q | 05 Nov 2018 | 2018 | Q3 | |
| Q2 2017 | -0.34 | -1.39 | -132% | 01 Apr 2017 | 30 Jun 2017 | 10-Q | 03 Aug 2017 | 2017 | Q2 | |
| Q4 2016 | -1 | -0.46 | +0.34 | +42% | 01 Oct 2016 | 31 Dec 2016 | 10-K | 15 Mar 2018 | 2017 | FY |
| Q3 2016 | -1 | -0.39 | -1.24 | -146% | 01 Jul 2016 | 30 Sep 2016 | 10-K | 15 Mar 2018 | 2017 | FY |
| Q2 2016 | 0 | 1.05 | +1.83 | 01 Apr 2016 | 30 Jun 2016 | 10-K | 15 Mar 2018 | 2017 | FY | |
| Q1 2016 | -2 | -0.82 | +1.09 | +57% | 01 Jan 2016 | 31 Mar 2016 | 10-K | 15 Mar 2018 | 2017 | FY |
| Q4 2015 | -3 | -0.8 | +0.03 | +3.6% | 01 Oct 2015 | 31 Dec 2015 | 10-K | 14 Mar 2017 | 2016 | FY |
| Q3 2015 | -3 | 0.85 | -1.23 | -59% | 01 Jul 2015 | 30 Sep 2015 | 10-K | 14 Mar 2017 | 2016 | FY |
| Q2 2015 | -1 | -0.78 | 0 | 0% | 01 Apr 2015 | 30 Jun 2015 | 10-K | 14 Mar 2017 | 2016 | FY |
| Q1 2015 | -1 | -1.91 | -1.04 | -120% | 01 Jan 2015 | 31 Mar 2015 | 10-K | 14 Mar 2017 | 2016 | FY |
| Q4 2014 | 0 | -0.83 | 01 Oct 2014 | 31 Dec 2014 | 10-K | 23 Feb 2016 | 2015 | FY | ||
| Q3 2014 | 2.08 | +2.79 | 01 Jul 2014 | 30 Sep 2014 | 10-K | 23 Feb 2016 | 2015 | FY | ||
| Q2 2014 | -0.78 | 01 Apr 2014 | 30 Jun 2014 | 10-K | 23 Feb 2016 | 2015 | FY | |||
| Q1 2014 | -0.87 | 01 Jan 2014 | 31 Mar 2014 | 10-K | 23 Feb 2016 | 2015 | FY | |||
| Q3 2013 | -0.71 | -1.28 | -225% | 01 Jul 2013 | 30 Sep 2013 | 10-Q | 10 Nov 2014 | 2014 | Q3 | |
| Q4 2012 | -2 | -1.15 | 01 Oct 2012 | 31 Dec 2012 | 10-K | 25 Feb 2014 | 2013 | FY | ||
| Q3 2012 | 0.57 | +1.02 | 01 Jul 2012 | 30 Sep 2012 | 10-K | 25 Feb 2014 | 2013 | FY | ||
| Q2 2012 | -0.54 | 01 Apr 2012 | 30 Jun 2012 | 10-K | 25 Feb 2014 | 2013 | FY | |||
| Q1 2012 | -0.4 | 01 Jan 2012 | 31 Mar 2012 | 10-K | 25 Feb 2014 | 2013 | FY | |||
| Q3 2011 | -0.45 | 01 Jul 2011 | 30 Sep 2011 | 10-Q | 06 Nov 2012 | 2012 | Q3 |
INFINITY PHARMACEUTICALS, INC. Annual Earnings Per Share, Basic (USD/shares)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2022 | -0.5 | +0.03 | +5.7% | 01 Jan 2022 | 31 Dec 2022 | 10-K | 28 Mar 2023 | 2022 | FY |
| 2021 | -0.53 | +0.15 | +22% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 28 Mar 2023 | 2022 | FY |
| 2020 | -0.68 | 01 Jan 2020 | 31 Dec 2020 | 10-K | 29 Mar 2022 | 2021 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.